Buy MOTS-C 40 mg in Australia
MOTS-C 40 mg is a research-grade peptide that is studied in cellular energy research, supplied in Australia by Australian Research Peptides to laboratories and researchers. The 40 mg vial measured 99.234% HPLC purity on 19 June 2026 at Janoshik, an independent laboratory commissioned by the manufacturer. This 40 mg vial costs A$149.99 and is in stock now, dispatched the same business day when paid before 12pm Sydney time, to all states and territories. MOTS-C is a 16-amino-acid peptide coded inside mitochondria, the cell's energy-making parts. For in vitro research purposes only.
Mitochondrial Research · Lyophilised Powder · HPLC-tested · SKU 58106
MOTS-C 10 mg40 mg
$149.99
Presentation
40 mg per vial
Grade
High-Purity Research Grade
Form
Lyophilised Powder
Category
Mitochondrial Research
Same-day dispatch on business-day orders completed before 12pm Sydney time, Mon–Fri
Tracked shipping Australia-wide · typically 1–2 business days to most areas by Express Post · free post over $199, free Express over $299
MOTS-C 40 mg: 99.234% purity by HPLC, in a report by Janoshik, an independent laboratory commissioned by the manufacturer, analysed 19 June 2026. View the certificate, or every report in the COA library.
For in vitro research purposes only. Not for human consumption. Not for animal consumption. This product is not a drug, food, cosmetic, or dietary supplement. No medical, therapeutic, or usage information is provided.
Browse all Mitochondrial Research
About MOTS-C 40 mg
MOTS-C's 16-amino-acid chain is coded by mitochondrial DNA rather than the nucleus, and is studied in energy-metabolism research involving the AMPK signalling pathway. This is the 40 mg MOTS-C vial, the larger of two, listed as 58106.
The 40 mg certificate records 99.234% — measured on this lot, never carried across from the 10 mg vial.
In vitro energy metabolism research purposes only. Australian Research Peptides does not supply MOTS-C for human or veterinary use.
MOTS-C is studied in energy-metabolism research, meaning how cells make and spend energy. Published work in mice and in cell cultures reports that it switches on AMPK, a protein that senses when a cell is short of fuel. This page covers the research field and what was measured, and reports no outcome in a person.
MOTS-C is coded by a short stretch of the 12S ribosomal RNA gene, which sits in mitochondrial DNA rather than in the nucleus. Peptides coded this way are called mitochondrial-derived peptides. Humanin was the first of the group to be described, and MOTS-C came after it. The name is written and searched as MOTS-C, MOTSc and MOTS C.
Lee and colleagues first described MOTS-C in 2015 in Cell Metabolism. They identified the reading frame it comes from and tested it against the AMPK signalling pathway in cells and in mice. Australian Research Peptides reports that this published record exists and makes no claim about the material in its own vials.
Australian Research Peptides lists MOTS-C in Australia in two strengths, 10 mg and 40 mg vials of freeze-dried powder, each sealed in tamper-evident glass. People also search for it as motsc and as a mitochondrial peptide. Orders are posted from within Australia to every state and territory, so none waits on an overseas shipment. Each lot is independently lab-tested, and the CoA library shows which MOTS-C strengths have a published certificate.
BAC water (bacteriostatic water) is also in our range.
Further reading on MOTS-C: Where Is the Best Place to Buy Peptides in Australia? · MOTS-C Research: What Studies Show and What Is Still Unknown
MOTS-C 40 mg specifications, storage and shipping
- Compound: MOTS-C
- Quantity: 40 mg
- SKU: 58106
- Presentation: sealed glass vial
- Form: Lyophilised Powder
- Grade: High-purity research grade
- Purity verification: HPLC-assayed to a minimum of 99% purity — the measured result is stated on the published Certificate of Analysis
- Identity confirmation: Mass spectrometry
- Certificates: issued by Janoshik, an independent laboratory, and published in the COA library
- Classification: In vitro research purposes only — laboratory reference material
- Lyophilised — long term
- −20 °C to −80 °C — long-term storage
- Lyophilised — short term
- 2–8 °C — refrigerated, for a few months
- Reconstituted
- 2–8 °C — use within 8–12 weeks
MOTS-C is HPLC-tested for purity and confirmed by mass spectrometry for identity. The full laboratory report is published in the COA library. MOTS-C is tested by Janoshik, an independent laboratory, commissioned by the manufacturer rather than by Australian Research Peptides.
- MOTS-C 40 mg: assayed purity 99.234% · measured content 46.46 mg · laboratory batch 2026-06 · analysed 19 June 2026
Business-day orders before 12pm Sydney time are dispatched the same day with tracked shipping. Standard delivery within Australia typically takes 2–5 business days. See Shipping & Delivery for details, and follow your parcel on the Track Order page.
For in vitro research purposes only. Not for human consumption. Not for animal consumption. Not a drug, food, cosmetic, or dietary supplement. No therapeutic or medical claims are made.
Questions about MOTS-C 40 mg
This MOTS-C 40 mg question guide from Australian Research Peptides covers the 40 mg listing on its own: its live price and stock, its published certificate, how it compares with the 10 mg vial, handling and storage, and the MOTS-C background it shares with the smaller vial. Start with the quick answers or open the topic you need.
Quick answers
Australian Research Peptides (ARP) sells MOTS-C 40 mg in Australia under 58106, at $149.99. Standard tracked post and Express Post carry MOTS-C 40 mg to all states and territories.
The 40 mg MOTS-C vial holds forty milligrams of freeze-dried peptide under a single seal, four times the amount in the 10 mg vial, with nothing else added by Australian Research Peptides. All forty milligrams come from one lot, so a long series of work runs on a single batch record.
MOTS-C 40 mg from Australian Research Peptides is 99.234% pure by HPLC, the figure on its published certificate of analysis, dated 19 June 2026. That report is by Janoshik, an independent laboratory commissioned by the manufacturer rather than by Australian Research Peptides, and the figure applies to the batch it tested. The full certificate is in the COA library.
Per milligram, MOTS-C 40 mg works out to about $3.75 — $149.99 across 40 mg. The 10 mg MOTS-C vial works out to about $9.00 a milligram.
The 40 mg MOTS-C vial suits work that runs for weeks or splits into several arms, where taking every measurement from one lot keeps the dataset on a single batch record. Once mixed, all forty milligrams share one fridge window, so work that pauses between stages may suit the 10 mg vial instead.
MOTS-C is a peptide, 16 amino acids long, that is coded by the DNA inside mitochondria, the part of the cell that makes most of its energy, rather than by the nucleus. Almost every other peptide in a cell is coded by DNA in the nucleus, which makes MOTS-C unusual. Researchers first described it in 2015. Australian Research Peptides supplies it as a freeze-dried powder, for laboratory work only.
Exact strength, quantity and listing fit
Four 10 mg MOTS-C vials cost $359.96; one 40 mg vial is $149.99 — $209.97 less, and three fewer vials to store.
The 40 mg MOTS-C vial is cheaper per milligram because what it costs to supply a vial, from the glass and seal to the label and packing, does not grow with the peptide inside. Forty milligrams carry that fixed cost instead of ten, which lowers the rate, and each MOTS-C strength page shows its live per-milligram figure.
MOTS-C from Australian Research Peptides comes in two strengths, a 10 mg vial and a 40 mg vial, and each figure is the amount of freeze-dried powder sealed in the glass, not a concentration or a purity level. Both vials hold the same sixteen amino acids in the same order; the 40 mg simply holds four times as much, and each strength has its own page and stock code.
Live price, stock and Australian buying
MOTS-C 40 mg costs $149.99 a vial (stock code 58106) at Australian Research Peptides, and two 40 mg MOTS-C vials come to $299.98.
Not on its own. MOTS-C 40 mg is $149.99, $49.01 under $199. MOTS-C clears it with two 40 mg vials. MOTS-C's 10 mg vial falls short too.
$162.98 delivered in Australia. MOTS-C 40 mg is $149.99, plus $12.99 for 58106 by Standard tracked post. Express Post makes 58106 $166.98.
Two vials of MOTS-C. At $149.99 each, two 40 mg vials make $299.98 — past $299, so 58106 ships free by Express Post, costing $299.98.
No, Chemist Warehouse does not stock MOTS-C, and neither does any pharmacy in any market, because this mitochondrial-derived peptide is not registered as a medicine anywhere in the world. That rules out pharmacy supply everywhere, not just in Australia, and there is no prescription version either, because a prescription needs a registered product behind it. Australian Research Peptides lists MOTS-C in 10 mg and 40 mg research vials.
Reconstitution and concentration calculations
Australian Research Peptides publishes no fill volume for 58106, so the amount is a decision for the work rather than one the listing sets. 58106 is 40 mg of dry MOTS-C: what the diluent changes is the solution, never the 40 mg sealed in the glass.
Once mixed, reconstituted MOTS-C keeps for up to twelve weeks in a 2–8 °C fridge, according to the Australian Research Peptides storage panel. That window applies only to the solution, since a sealed dry vial has its own separate rows on the same panel. MOTS-C contains two methionines and a tryptophan, which oxidise easily, so it has more to lose to air and light than a shorter chain. Keep it in the dark, and split it into portions rather than going into one vial again and again.
MOTS-C is normally dissolved in an aqueous (water-based) diluent for laboratory work, which turns the dry powder in the vial into a liquid that can be measured with a pipette. The vial holds only dry powder, with no water or carrier added, and the amount of liquid added sets the concentration.
MOTS-C mixed too concentrated can set to a gel in the fridge, sometimes days later, because in a strong solution its chains link up with each other. Other peptides beside it in the same fridge can stay liquid. A gelled vial is no longer an even solution, so it shouldn't be used. Don't mix MOTS-C too strong: use more bacteriostatic water than you would for most peptides, so the solution stays weaker.
Product identity and research background
MOTS-C stands for mitochondrial open reading frame of the 12S ribosomal RNA type-c, a name that describes where it sits in the genome rather than what it is chemically. An open reading frame is a stretch of genetic code that can be read as instructions for making a peptide, and MOTS-C is classed as a mitochondrial-derived peptide.
MOTS-C is studied for its action on AMPK, a switch that cells turn on when they run short of energy, and the findings so far come from cells and from mice. Lee's 2015 Cell Metabolism report describes it blocking part of the folate pathway, which builds up a molecule called AICAR, and AICAR switches AMPK on. Kim 2018, in the same journal, found that under metabolic stress the peptide also moves into the cell nucleus within about thirty minutes. There it binds antioxidant response elements, stretches of DNA that switch stress-response genes on, and changes how strongly those genes are read.
A MOTS-C vial holds freeze-dried MOTS-C peptide and nothing else, a white to off-white solid that is all peptide rather than peptide mixed through a filler. The glass is sealed under a tamper-evident cap. Nothing is dissolved, blended or divided before dispatch, and the seal stays closed until a laboratory opens it.
No pharmacokinetic profile has been published for MOTS-C, meaning no study has measured how fast it is absorbed, spread through the body or cleared. Santhanam's 2026 rat-heart paper in Naunyn-Schmiedeberg's Archives of Pharmacology ends by calling for pharmacokinetic studies, which confirms that none exist yet. Australian Research Peptides publishes no clearance figure and won't estimate one. What it does publish for MOTS-C is a certificate of analysis for each strength that has one, and the CoA library shows which strengths those are.
MOTS-C is a chain of 16 amino acids, and the sequence that PubChem records for it under CID 146675088 runs Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg. Gao's 2023 review in Metabolites reports that the first eleven positions are highly conserved across species. Residue is the technical word for one amino-acid unit in a chain, so sixteen residues and sixteen amino acids mean the same thing. Every Australian Research Peptides MOTS-C vial holds this same chain.
The published literature records nothing after MOTS-C exposure ends, because no study has looked at what happens once exposure stops. Research on this mitochondrial peptide is only about a decade old, mostly in mice and cultured cells, and everything was measured during the experiment itself. Nothing has been documented either way, and the honest answer is that the question has never been studied.
No, Australian Research Peptides does not supply MOTS-C as a tablet, capsule or nasal spray, and lists it only as a freeze-dried powder in a sealed glass vial. The published research on MOTS-C comes from cell culture and animal models, not from oral or nasal preparations. No regulator anywhere has approved a MOTS-C product in any form, so there is no approved tablet either. A pre-mixed product also uses up part of its stability window before it is even posted, while a sealed freeze-dried vial only starts that window when the researcher mixes it.
Storage, condition and testing
Yes, it is normal for a MOTS-C vial to look almost empty, because even the 40 mg vial holds only a small pale cake of powder rather than a vial full of it. Dried peptide takes up very little room, and no filler or carrier is added, which is exactly why there is so little to see.
MOTS-C should be stored dry and tightly sealed below -15 °C, and colder still for the long term, in line with Bachem's handling guidance for freeze-dried peptides. This matters because MOTS-C contains two methionines and a tryptophan, amino acids that oxidise more easily than most. Cold glass draws moisture from the air, so let the sealed vial warm up in a desiccator before opening it. Solutions don't keep well, so freeze them in single-use portions.
MOTS-C usually looks cloudy after mixing because of air, since swirling or turning the vial over repeatedly pushes bubbles through the liquid that scatter light just like real cloudiness. The bubbles clear once the vial is left alone, and a 40 mg vial holds a lot of powder, so it takes longer to clear than a smaller fill. Anything still opaque after that, or grit that won't dissolve, is not just bubbles.
Australian Research Peptides publishes storage conditions for MOTS-C rather than an expiry date, so this page gives no shelf-life figure for a sealed vial, and none should be borrowed from elsewhere. The storage panel gives the sealed dry vial two options, frozen for the long term or refrigerated for a few months, and gives a mixed solution a shorter window of its own. How long a freeze-dried vial lasts depends on how it has actually been kept, which is why the conditions are what get published.
Yes, MOTS-C 40 mg was analysed on 19 June 2026 by Janoshik, an independent laboratory commissioned by the manufacturer, which recorded 99.234% purity by HPLC. The mass has to match a sixteen-amino-acid chain, since a chain missing even one amino acid would weigh something different. No salt form is published, because it hasn't been confirmed for this material. A matching certificate is currently published for the 40 mg vial. Open the 40 mg certificate.
Delivery, payment and access questions
Australian Research Peptides sells MOTS-C to laboratories and researchers in Australia for in vitro research purposes only, not as a medicine, and it is not supplied for use in people or animals. No Australian Research Peptides material describes such use. MOTS-C is a research compound, not an approved treatment, and it has not been assessed as one. Anyone buying it is responsible for the rules that apply to their own work.
No, MOTS-C is not FDA approved, and no drug regulator in any country has approved it, so no registered medicine contains it. Lee and colleagues only described this mitochondrial-encoded peptide in 2015, so its research record is short and almost entirely preclinical, and none of it has been submitted for review. A vial of MOTS-C is unregistered material intended for laboratory experiments.
Yes, MOTS-C is banned in sport at all times, both in and out of competition, under the World Anti-Doping Agency's prohibited list. Unusually, the list names it in full, as mitochondrial open reading frame of the 12S rRNA-c, and groups it with AICAR as an AMPK activator among the metabolic modulators. Sport Integrity Australia oversees testing for Australian athletes.